Clinuvel Pharmaceuticals (Clinuvel Pharmaceuticals) Days Inventory : 1,880.41 (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Clinuvel Pharmaceuticals Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Clinuvel Pharmaceuticals's Average Total Inventories for the six months ended in Dec. 2023 was $7.40 Mil. Clinuvel Pharmaceuticals's Cost of Goods Sold for the six months ended in Dec. 2023 was $0.72 Mil. Hence, Clinuvel Pharmaceuticals's Days Inventory for the six months ended in Dec. 2023 was 1,880.41.

The historical rank and industry rank for Clinuvel Pharmaceuticals's Days Inventory or its related term are showing as below:

CLVLF' s Days Inventory Range Over the Past 10 Years
Min: 57.41 Med: 93.79 Max: 408.56
Current: 408.56

During the past 13 years, Clinuvel Pharmaceuticals's highest Days Inventory was 408.56. The lowest was 57.41. And the median was 93.79.

CLVLF's Days Inventory is ranked worse than
77.04% of 649 companies
in the Biotechnology industry
Industry Median: 191.36 vs CLVLF: 408.56

Clinuvel Pharmaceuticals's Days Inventory increased from Dec. 2022 (296.89) to Dec. 2023 (1,880.41). It might indicate that Clinuvel Pharmaceuticals's sales slowed down.

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Clinuvel Pharmaceuticals's Inventory Turnover for the six months ended in Dec. 2023 was 0.10.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Clinuvel Pharmaceuticals's Inventory-to-Revenue for the six months ended in Dec. 2023 was 0.34.

Clinuvel Pharmaceuticals Days Inventory Historical Data

The historical data trend for Clinuvel Pharmaceuticals's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinuvel Pharmaceuticals Days Inventory Chart

Clinuvel Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Inventory

Get a 7-Day Free Trial

75.11

65.15

168.19

92.24

237.52

Clinuvel Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Inventory	Get a 7-Day Free Trial															146.70	71.71	296.89	187.08	1,880.41

Competitive Comparison of Clinuvel Pharmaceuticals's Days Inventory

For the Biotechnology subindustry, Clinuvel Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clinuvel Pharmaceuticals's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clinuvel Pharmaceuticals's Days Inventory distribution charts can be found below:

* The bar in red indicates where Clinuvel Pharmaceuticals's Days Inventory falls into.

Clinuvel Pharmaceuticals Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Clinuvel Pharmaceuticals's Days Inventory for the fiscal year that ended in Jun. 2023 is calculated as

	Days Inventory (A: Jun. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Jun. 2022 )	+	Total Inventories (A: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2023 )	*	Days in Period
=	( (1.287	+	6.389)	/	2 )	/	5.898	*	365
=	3.838					/	5.898	*	365
=	237.52

Clinuvel Pharmaceuticals's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (6.389	+	8.407)	/	2 )	/	0.718	*	365 / 2
=	7.398					/	0.718	*	365 / 2
=	1,880.41

Clinuvel Pharmaceuticals (OTCPK:CLVLF) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Clinuvel Pharmaceuticals's Inventory Turnover for the six months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.718	/	7.398
	=	0.10

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Clinuvel Pharmaceuticals's Inventory to Revenue for the six months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	7.398	/	21.591
	=	0.34

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Clinuvel Pharmaceuticals Days Inventory Related Terms

Thank you for viewing the detailed overview of Clinuvel Pharmaceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Clinuvel Pharmaceuticals (Clinuvel Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clinuvel Pharmaceuticals Ltd (OTCPK:CLVLF) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

CLVLY:USA UR9:Germany CUV:Australia

Address

535 Bourke Street, Level 11, Melbourne, VIC, AUS, 3000

Website

https://www.clinuvel.com

Clinuvel distributes a single-product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the U.S.